$ZBRA

ZEBRA TECHNOLOGIES CORP

Zebra designs, manufactures and sells products, software and services that help businesses digitize and automate workflows. Its customers and end-users span retail and e-commerce, manufacturing, transportation and logistics, healthcare, hospitality, the public sector and other industries. Zebra is headquartered in Lincolnshire, Illinois, and operates in 129 facilities with approximately 10,700 employees worldwide. Zebra reports two segments: Connected Frontline, which includes mobile computers, customer-facing and self-service solutions, workflow optimization software and services; and Asset Visibility and Automation, which includes barcode and card printers, scanners, machine vision, RFID and real-time location systems, supplies and sensors, and related services. Zebra makes money by selling hardware and consumables, and by providing software subscriptions, maintenance, support, repair, managed and professional services. It sells directly and through distributors, resellers and other channel partners.

1
0
0

No SEC Form 4 filings for $ZBRA in the last 30 days.

See all $ZBRA insider activity →
High

Zebra Technologies Sees 2027 Growth as Delivery Refreshes Offset Memory Cost Pressures

Zebra Technologies (ZBRA) raised prices to offset higher costs, with no broad customer project deferrals. AI applications and productivity improvements are expected to drive growth. The company anticipates $1B in free cash flow this year, with $400M remaining under its repurchase authorization. Investor sentiment has improved due to secured memory supply and interest in AI and automation.

Why Zebra stock is up today

Zebra Technologies (ZBRA) shares rose 3.5% after Jefferies initiated coverage with a Buy rating and $382 price target, citing 22% EBITDA margins and 8% topline growth forecast for fiscal 2027. The stock later settled at $332.38, up 3.4%.

Nvidia downgraded, Mercury Systems upgraded: Wall Street's top analyst calls

JPMorgan upgraded Mercury Systems (MRCY) to Overweight with a $102 target, citing Q3 performance. Republic Services (RSG) was upgraded to Overweight with a $295 target, expecting positive waste volume growth in 2027. Raymond James upgraded Liquidia (LQDA) to Strong Buy with a $77 target, citing strong demand and legal settlement. Piper Sandler upgraded Alpha Tau (DRTS) to Overweight with a $22 target, highlighting its technology.

ZBRA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ZBRA (ZEBRA TECHNOLOGIES CORP). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent ZBRA coverage spans financial news, market movers and earnings.

What's driving ZBRA

AlphAI scores every news story that mentions ZBRA with an AI model for sentiment and relevance, and aggregates insider trades from ZEBRA TECHNOLOGIES CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ZBRA

Score

Zebra Technologies Sees 2027 Growth as Delivery Refreshes Offset Memory Cost Pressures

Zebra Technologies (ZBRA) raised prices to offset higher costs, with no broad customer project deferrals. AI applications and productivity improvements are expected to drive growth. The company anticipates $1B in free cash flow this year, with $400M remaining under its repurchase authorization. Investor sentiment has improved due to secured memory supply and interest in AI and automation.

Why Zebra stock is up today

Zebra Technologies (ZBRA) shares rose 3.5% after Jefferies initiated coverage with a Buy rating and $382 price target, citing 22% EBITDA margins and 8% topline growth forecast for fiscal 2027. The stock later settled at $332.38, up 3.4%.

Nvidia downgraded, Mercury Systems upgraded: Wall Street's top analyst calls

JPMorgan upgraded Mercury Systems (MRCY) to Overweight with a $102 target, citing Q3 performance. Republic Services (RSG) was upgraded to Overweight with a $295 target, expecting positive waste volume growth in 2027. Raymond James upgraded Liquidia (LQDA) to Strong Buy with a $77 target, citing strong demand and legal settlement. Piper Sandler upgraded Alpha Tau (DRTS) to Overweight with a $22 target, highlighting its technology.

Here are Wednesday's biggest analyst calls: Nvidia, Apple, CoreWeave, Corning, Unilever, Teradyne & more

Analysts made notable calls on Nvidia (downgraded by Baird), Apple (neutral reiterated by UBS), CoreWeave (buy reiterated by Goldman Sachs), and others. Key points include Nvidia's delayed data center forecasts, Apple's lower iPhone wait times, and CoreWeave's potential for outsized returns. Other companies mentioned include Alpha Tau Medical, Republic Services, CareDx, Mentari, Unilever, Mercury Systems, Teradyne, FormFactor, Corning, Cognex, Littelfuse, and Zebra Technologies.

Morgan Stanley raises Zebra Technologies price target on demand outlook

Morgan Stanley raised its price target for Zebra Technologies (ZBRA) to $380 from $360, citing improved demand visibility and a durable revenue growth outlook. The stock is currently trading at $329.50, down 14% over the past week. Zebra's recent Q3 2026 earnings beat expectations, with revenue of $1.61 billion and EPS of $4.95, but investors remain concerned about margin pressure and pricing actions.

Zebra Technologies’ Record Quarter Came With a 2027 Margin Warning

Zebra Technologies reported Q3 revenue of $1.61B, up 22.3% YoY, and raised full-year sales growth target to 17%. Adjusted earnings of $4.95 per share beat estimates. However, shares fell 17% premarket due to 2027 margin concerns, with CEO citing rising memory chip costs and price hikes. The company expects lower margins in 2027, with 2026 figures including tariff refunds.

Stocks making the biggest moves midday: Apple, Palantir, Nvidia, Coinbase, Bloom Energy & more

Coinbase surged 8% after mixed Q3 results and a price target cut. Shopify fell 5% despite revenue near estimates. Bloom Energy rose 10% after an upgrade. Thomson Reuters dropped 7.5% on earnings miss. ON Semiconductor gained 4% on earnings beat. DuPont climbed 9% with raised outlook. Fiserv jumped 12% on strong earnings. AI-related stocks rebounded. Revvity gained 11% on raised guidance. Pfizer eased 1% with earnings beat. Zebra fell 6% despite beating estimates.

Related tickers